SLC6A3 and attention deficit-hyperactivity disorder: DAT expression is associated with ADHD (see Pramod et al., 2013 for review), including the site of action for many ADHD medications (Fone and Nutt, 2005; Gerlach et al., 2013; Faraone, 2018), so these results are particularly noteworthy.